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Abstract
Background: For decades, mass spectrometry data has been analyzed to investigate a wide array of research
interests, including disease diagnostics, biological and chemical theory, genomics, and drug development. Progress
towards solving any of these disparate problems depends upon overcoming the common challenge of
interpreting the large data sets generated. Despite interim successes, many data interpretation problems in mass
spectrometry are still challenging. Further, though these challenges are inherently interdisciplinary in nature, the
significant domain-specific knowledge gap between disciplines makes interdisciplinary contributions difficult.
Results: This paper provides an introduction to the burgeoning field of computational mass spectrometry. We
illustrate key concepts, vocabulary, and open problems in MS-omics, as well as provide invaluable resources such
as open data sets and key search terms and references.
Conclusions: This paper will facilitate contributions from mathematicians, computer scientists, and statisticians to
MS-omics that will fundamentally improve results over existing approaches and inform novel algorithmic solutions
to open problems.
Background
Robust data processing tools for MS data are lagging
behind the substantial advances occurring in instrumen-
tation and protocol [1]. One reason for this is that few
outside experts–mathematicians, computer scientists,
and statisticians–have climbed the learning curve
(usually requiring several years of dedicated study) to
understand the terminology, chemical theory, workflows,
and challenges of MS-omics (proteomics, lipidomics,
and metabolomics). This sort of interdisciplinary learn-
ing curve is not unusual in bioinformatics; however, the
influx of external experts to genomics has not been seen
to date in MS-omics. One reason for this is the lack of
a succinct and cogent introductory resource that can
bring outside experts to a basic but functional level of
MS-omics familiarity.
In this primer, we will elucidate the mechanisms of
MS-omics, the problems it is used to solve, key concepts
and terms found in the literature, and open problems
and their salient literature. The purpose of this tutorial
is to expedite the new researcher’s acquisition of a func-
tional knowledge of MS-omics sufficient for contribu-
tion to the field.
Results and discussion
Relationship of genomics, proteomics, lipidomics, and
metabolomics
The exponential growth of genomics studies during the
last ten years has not been matched by corresponding
research in MS-omics [2]. Genomics researchers have
several peer-reviewed conferences in which to publish
their results. To the best of our knowledge, there has
not been a single peer-reviewed conference to date on
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lipidomics or metabolomics, let alone any specifically
addressing algorithmic approaches to problems specific
to either area, although there are periodic special geno-
mics conferences dedicated to proteomics. Several exist-
ing venues labeled as bioinformatics will not accept
papers on MS-omics, as their stated area of interest is
limited to a distinct subfield of bioinformatics such as
genomics. This phenomenon of focus on genomics is
also reflected in institutional research programs. In a
recent review of 78 post-secondary degree-granting
bioinformatics programs, 22 programs noted a research
emphasis in genomics, while 18 noted a research
emphasis in proteomics. Not a single institution listed a
research program in lipidomics or metabolomics [3].
The biological reach and impact of research in MS-
omics is so extensive that it can be argued that MS-omics
should now be the highest priority of systems biology [4].
From a pragmatic perspective, the large set of fresh pro-
blems and substantial potential for impact in MS-omics
ought to be very attractive to those in more crowded
disciplines.
Proteomics
Proteomics is the study of biological processes via the
analysis of protein expression or state in cells or tissue.
Proteins are ubiquitous building blocks of life, and they
are composed of peptides, which are chains of amino
acids built by translating mRNA. There are 20 amino
acids, uniquely abbreviated with a single letter. Peptides
thus can be described as a string of the letters corre-
sponding to the amino acids. Though protein sequences
are determined by DNA sequences, post translational
protein modifications (such as acetates, phosphates,
lipids etc.) are not as easily predicted. These modifica-
tions quickly diversify and regulate/complicate protein
function and cellular protein composition and are char-
acteristic in most cellular processes and diseases. There-
fore, the aim of MS-proteomics is to provide data that
DNA sequences cannot–namely, individual protein con-
centrations and identification of post-translational
modifications.
Lipidomics
Lipidomics is the systems-level analysis of lipids (fat mole-
cules) and their interactions [5]. It is a science still in its
infancy but one that promises to revolutionize biochemis-
try [4]. Lipids are grouped into eight categories that share
common physical and chemical properties [4,6], and there
are currently some 38,000 documented lipids.
Lipids that occur rarely or in small quantities are often
the most effectual lipids in biological processes, meaning
they are particularly important in disease diagnostics and
in understanding pathology [5]. Lipidomics can elucidate
the pathology and treatment of many diseases such as
cancer, diabetes, obesity, cardiovascular disease, arthritis,
asthma, inflammatory bowel disease, Alzheimer’s and
others due to the associated disruption of lipid metabolic
enzymes and pathways [7,2,8,5]. A better understanding
of lipidomics could significantly advance diagnostic med-
icine as well as provide novel treatment options.
Metabolomics
Metabolomics is the study of metabolomes–small mole-
cular end products of cellular regulatory pathways [9]
that can provide a snapshot of cell physiology. Metabo-
lites are much smaller than proteins and smaller than
most lipids. Their small size precludes the direct overlap
of some techniques used in proteomics or lipidomics, but
they may be generally analyzed in similar ways. Lipids
may be classified as a subset of metabolites; however,
mass spectrometrists typically consider lipids distinct
from metabolites because analytically they must be trea-
ted separately (i.e., require different solvents).
MS-omics pipeline
The workflow from sample preparation to result quantifi-
cation, can be split into two consecutive pipelines: the
wet-lab pipeline and the data processing pipeline. The
data processing pipeline consists of many possible proces-
sing steps that take the data resulting from the wet-lab
pipeline (the mass spectrometer output) to the end result:
identification and quantification (see Figure 1). The quality
of each step in the pipeline affects the sensitivity and relia-
bility of the outcome [10]. There are many optional steps,
some of them very popular. We will describe the essential
and some optional steps.
All MS experimental data share a set of descriptive
keywords that are essential for referencing components
of the output map (see Figure 2). A comprehensive
reference of key MS terms is provided in [11].
Sample preparation
The details of sample preparation are beyond the scope
of this paper. However, at a general level, sample pre-
paration strategies prior to mass spectral analysis are
based on isolating analytes of interest and removing all
other contaminating molecules. For instance, filters can
be used to separate high molecular weight proteins from
low molecular weight lipids and metabolites, or contam-
inates. Other sample preparation techniques exploit ana-
lyte hydrophobicity, charge, and analyte-specific affinity.
The degree of specificity in sample preparation is deter-
mined by the end goal of the experiment [12]. For
example, if an experiment requires the analysis of only
phosphorylated proteins, the sample preparation should
isolate only phosphorylated proteins. Of course, this is
very challenging but using an appropriate sample pre-
paration strategy specific to an experimental need signif-
icantly simplifies mass detection and data analysis and
in some cases is required to identify analytes of interest.
Proteomics, lipidomics, and metabolomics each have
unique considerations in sample preparation.
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Figure 1 The MS-omics pipeline. A sample is introduced to an ionization mechanism with or without a preliminary separation technique,
where particles receive a charge enabling the detector to estimate the mass-to-charge ratio (m/z) and intensity of each analyte. If the system
has tandem mass spec capabilities, some precursor ions (MS1) are selected for fragmentation (MS/MS). Data processing techniques prepare the
data to be quantified via statistical methods and identified via matches to theoretical databases.
Figure 2 Common nomenclature. Each portion or summary of an MS run is referred to by a different name. A spectrum contains all points
with a single RT value. The sum of signals across all spectra is called the total ion spectrum (TIS). A slice of data containing a contiguous m/z
range extending across all RT is called an extracted ion chromatogram (XIC). While the total ion chromatogram (TIC) is the sum of all signals
across all m/z, the base peak chromatogram (BPC) is the set containing the most intense signal for each RT across all m/z. An isotope trace is the
signal produced by a single ion of a single analyte (i.e., a peptide or a lipid) at a particular charge state. An isotopic envelope trace is the group of
isotopic traces produced by a single analyte at a particular charge state. Note that certain terms like peak, feature, and chromatogram, are
overloaded in the literature and as such are exceedingly unclear.
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Introduction methods
Direct injection refers to infusing the sample directly
into the mass detector. This is usually done with some
sort of machine to make the flow constant.
While it is sometimes advantageous to allow all ana-
lytes to flow through detection at once, most MS experi-
ments of complex samples will use chromatography due
to its ability to spread out analytes over time, making it
less likely that the ionization capacity will be overcome
by large quantities of analyte or background ions, a phe-
nomenon called ion suppression.
Chromatography disperses the introduction of analytes
into the mass detector through time based on some che-
mico-physico property (hydrophobicity, for instance). All
chromatography systems have two phases: the stationary
phase and the mobile phase. The stationary phase causes
analyte separation and the mobile phase carries the ana-
lytes through the chromatographic column to the mass
spectrometer. Methods include:
• LC-MS - mass spectrometry coupled to liquid
chromatography. Liquid chromatography uses a
liquid mobile phase and a column packed with che-
mically derivated beads as a stationary phase. The
mobile phase is composed of a two-liquid gradient.
Changes in the gradient (the percent composition of
each liquid) cause analytes to be slowly released
from the column and enter the mass spectrometer.
Different stationary phases can separate analytes
based on hydrophobicity, charge, size, or affinity.
However, the most common stationary phases for
LC-MS on biomolecules are reversed phase (hydro-
phobic) and strong cation (charge) [13].
• GC-MS - mass spectrometry coupled to gas chro-
matography. In gas chromatography systems the
mobile phase is an inert gas (such as helium) and
the stationary phase is a column designed to sepa-
rate molecules based on polarity. The gradient is
temperature increase; molecules with a high affinity
for the column elute at higher temperatures.
• CE-MS - mass spectrometry coupled to capillary
electrophoresis. Electrophoresis differs from chroma-
tography, relying on electric fields, rather than
mobile and stationary phases, to separate molecules
[14]. Capillary electrophoresis uses an electric field
applied to long narrow capillaries to separate mole-
cules based on size, charge, and flow resistance
through the capillary.
Multidimensional chromatography (sometimes referred
to as tandem chromatography) refers to two chromato-
graphic systems applied to the same system. In the case
of LC-GC-MS, for example, analytes are introduced into
the gas chromatography system as they elute from the
LC system, with each system causing analytes with speci-
fic properties to elute with precedence. A more common
multidimensional system in MS-omics is MUDPIT.
MUDPIT uses two orthogonal separation strategies like
strong cation ion exchange (charge based) and reversed
phase (hydrophobicity based) chromatography to achieve
greater resolution.
Ionization methods
Analytes must be ionized (i.e., in a charged state) in
order to be detected by the mass spectrometer. Electro-
spray ionization (ESI) was developed in 1994 and is the
most popular in MS-omics due largely to its ability to
ionize unstable molecules without breaking chemical
bonds and to the diverse range of analytes that can be
ionized by the method [15,16]. Other methods include
atmospheric pressure chemical ionization (APCI) [17],
matrix-assisted laser/desorption ionization (MALDI)
[17], and electron-ionization (EI) [17]. Ionization meth-
ods for ms-omics are generally referred to as soft ioniza-
tion methods and include ESI and MALDI. EI is a harsh
ionization method and will destroy most biomolecules
except for very stable lipids and metabolites.
Mass detection
As charged particles are passed through the mass spectro-
meter, the mass-to-charge ratio (m/z) of detected particles
is registered. A single scan on the resulting output repre-
sents a snapshot of the precursor ions passing through the
mass spectrometer at that particular retention time (RT).
The ions in this stage are called precursor ions because in
tandem mass spectrometry (MS/MS), ions in small m/z
windows are captured for fragmentation and MS detection
a second time, yielding a second set of ions called product
ions that can be used to identify precursor ions by match-
ing their MS/MS patterns to a database of possibilities. It
is important to understand that the ratio of solution
selected for MS/MS fragmentation is low, normally cap-
turing only 10-20% of the precursor (MS1) data. Because
most MS/MS systems autoselect what segments to capture
based on intensity, much of that portion overlaps between
replicates. Of that 10-20%, less than 60% are identified via
database lookup, and even that is subject to false positive
identifications [18].
An analyte can contain certain naturally occurring rare
isotopes, such as carbon-13. These isotopes tend to occur
in individual analytes in known quantities, causing a
characteristic pattern called an isotopic envelope (see
Figure 2). The envelope is characterized by the number of
and relative intensity between its isotopes. The monoisoto-
pic peak, or peak that appears at the theoretical mass dis-
counting any attached heavy isotopes, usually appears
alongside the slightly heavier masses of any portion of the
peptide or lipid in the sample that contains heavy isotopes.
When an analyte exists in a run in more than one
charge state (a very common occurrence due to variability
Smith et al. BMC Bioinformatics 2014, 15(Suppl 7):S9
http://www.biomedcentral.com/1471-2105/15/S7/S9
Page 4 of 14
in ionization), its isotopic envelope will reappear in a com-
pressed and shifted form due to increased charge, as illu-
strated in Figure 3. The equation for the shift is specific to
the source of the charge. For instance, a charge can be
induced by the addition of a proton, in which case the
shift is defined by (µ + k)/charge m/z with a gap between
ions in the isotopic envelope of 1/k, where k is the
charge of the analyte (3+, 2+, 1+, and 1+, respectively
in Figure 3) and µ is the m/z of the single-charged
analyte (this is the analyte with only a +1 charge–399 in
Figure 3).
Mass spectrometers output raw data–a large collection
of data points each consisting of a tuple of m/z, inten-
sity, and time (RT) either in profile or centroid form.
Profile data contains all data points registered by the
mass spectrometer (see Figure 4a), while centroid data
has been reduced to data points that represent the local
maxima in a single spectrum, a distribution of data over
an m/z range for a given RT (see Figure 4b). Centroid
data is much more concise than profile data, but the
reduction incurs information loss.
Experiments can run in full scan mode–where the full
range of m/z values is read–or the mass spectrometer
can scan only certain m/z values (called single reaction
monitoring in the case of one m/z value or multiple
reaction mode in the case of several) [17].
Mass spectrometers have varying characteristics
depending on the mechanisms used for mass detection,
each with a different resolution. Resolution at a certain
m/z is given by the ratio of that m/z to the smallest m/z
gap between two distinguishable ions. Higher resolution
instruments yield narrower profile peaks (see Figure 4a),
allowing the signals from two distinct ions to be distin-
guished despite their similarity in m/z.
Figure 3 Deisotoping. A contrived example of deistoping. The same molecule is displayed here in three reduced isotopic envelopes (denoted
by color) created from single- ([M + H]+1), double- ([M + H]+2) and triple-charged ([M + H]+3) instances of the molecule. The monoisotope (the
lowest m/z ion) from each isotopic envelope is combined to form the deistoped monoisotopic peak.
Figure 4 A profile (a) and centroid (b) version of the same spectrum. The profile raw data detected by a mass spectrometer consists of
distributed signal across m/z values at each point where an ion is detected. Centroid data is raw data that has been processed by an algorithm
to retain only the local maximum in each range in which an ion is detected. Because each ion detected creates an m/z distribution of signal,
the distribution itself (in profile mode) or the maximum to which it is reduced (its centroid) is sometimes called a peak. This ion intensity
distribution along m/z is not to be confused with the distribution of ion intensity along time in chromatographic studies (see Figure 2).
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Data processing
Data processing consists of each of the possible steps in
the MS-omics pipeline (Figure 1) involving digital
manipulation of the mass spectrometer data or products
from that data. These methods are constantly being
improved upon and are discussed in detail in Section.
Here, we provide a high-level overview of the role of
data processing in the MS-omics pipeline.
The first step in data processing is handling the raw
data produced by the mass spectrometer. Algorithms for
noise reduction, feature detection, and correspondence
exist that operate on the raw data. However, many
require preliminary conversion out of the proprietary
data format of the instrument and into an open data
type (see below for a discussion of existing data types).
It is important to note that, due to the size of the data
sets, random access data processing–where only a por-
tion of the data file is loaded into memory at a time–is
a must, although some current tools load the full file
and are therefore prone to crashing and subject to file
size limits as memory is exhausted.
Prior to analyte identification, the data must be
denoised, peak-picked, featuredetected, deisotoped, and
deconvoluted. These are significant and open problems
and are discussed in more detail below.
Analyte identification follows data processing. Here,
one of several available databases are used to compare
the experimental feature observations (i.e. isotopic
envelopes, isotopic traces, etc.) to theoretical patterns.
These include Sequest [19] for proteins, LIPIDMAPS
[20] for lipids, and METLIN [21] for metabolites. Due
to incomplete/growing databases and noisy data, closest-
match assignment is prone to false positives and mis-
matches. Statistical analysis is almost always incorpo-
rated in this or prior steps in order to ascertain the
significance of the identification.
The ultimate goal of data processing is to yield the
quantity of each analyte. The identification and quantity
of analytes, as well as the underlying raw data, must be
stored in data structures that allow for efficient access
and manipulation of the data.
Data types
Raw data is a general label that actually describes a set of
data formats specific to the vendor of the instrument.
Many data converters from raw to open data formats
exist. One popular converter is pwiz (http://proteowizard.
sourceforge.net/). The Network Common Data Form
(NetCDF), a generic open science data format, is an early
data format that is still in use in some applications.
mzXML is an open XML based data format with wide
support. mzML was developed to replace mzXML and has
more information from the raw data encoded and uses
extensible ontologies to encode meta-data. mzQuantML is
an open data format specifically intended for the storage
of quantities associated with identified feature data. mzI-
dentML and pepXML are standards designed to facilitate
database identity searches. Annotated Putative Peptide
Markup Language (APML) is an XML standard designed
to provide a single data file encoding of the original data
set and its modifications via data processing tools [22].
Data sets
Lack of labeled data
The prevailing problem in developing and evaluating
computational approaches to MS-omics problems is the
lack of labeled data [23]. Labeled data is difficult to
obtain both because of the size of data sets–which can
easily consist of millions of data points per file and hun-
dreds of GBs of files for a replicate experiment series–
and the undependability of hand-labeling–which is both
time consuming and subjective. Several approaches for
mitigating this problem exist: qualitative metrics, spiked
mixtures, and in silico simulated data.
Qualitative metrics Evaluation metrics that do not use
ground truth avoid the need for labeled data. For exam-
ple, replicate alignment quality can be assessed via the
Pearson correlation coefficient, feature overlap rate, or
coefficient of variation. This approach is sub-optimal, as
a good score on a qualitative metric does not necessarily
translate into a good quantitative score using labeled
data, but it is easy to compute and is comparable across
problem instances.
Spiked mixtures Commercially available purified and
quantified measures of a specific analyte are combined to
produce a data set with known composition and quantity.
These samples are not exactly ground truth, however. Due
to ionization inefficiencies, environmental contaminants,
and the variability of mass spectrometry, no instrument
will report the same quantity and composition predicted
by a spiked mixture. What’s more, a mixture of a few ana-
lytes, which often do not co-occur in nature, is hardly
representative of real-world scenarios, in which complex
samples can easily contain hundreds of thousands of dis-
tinct analytes. To create more realistic conditions, spiked
mixtures can be added to samples where the spiked an-
alytes are not expected to occur. However, a method’s
accuracy on a few analytes is not necessarily indicative of
performance across all analytes, particularly given the
variability and limitations of MS/MS, which is commonly
used to single out the m/z of the expected analytes but
cannot be expected to capture the gross majority (≈ 80 −
90%) of the remaining sample.
In silico simulated data Simulated data is used in the
field to refer to real-world data sets that have been pur-
tubed with m/z shifts or intensity value modifications in
order to create psuedo-new data without having to rerun
costly experiments. True simulated data, called in silico to
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identify that it as purely sourced from simulation algo-
rithms on a computer, is a relatively new advent in MS-
omics. Creating realistic in silico data requires the analysis
of many ground truth datasets, which creates a chicken
and egg problem, as the difficulty of obtaining ground
truth datasets is the very reason an in silico simulator
would be beneficial.
Sources of open data
To facilitate strictly algorithmic advances in MS-omics,
to avoid the need for a costly wet lab for creating mass
spectrometry data, and to aid in evaluative comparisons
against existing methods, more and more practitioners
are making their data freely available online. Although
any serious foray into MS-omics should certainly
include a collaborator with mass spectrometry assets
and formal training, we present a list of some of these
open data sets in order to aid those who are interested
in investigating MS-omics for the first time as well as
more seasoned investigators who would simply like to
make a case for the generality of their methods.
Lange et al. have provided two proteomic and two
metabolomic data sets [24] which they have used to
assess the quality of several alignment algorithms at
http://msbi.ipb-halle.de/msbi/caap. The data is already
segmented into reduced isotopic envelopes (isotopic
envelopes whose isotopic traces are integrated into a
single point).
Listgarten et al. provide centroided replicate data with
spiked-in peptides [25]. There are two data sets: a set of
11 replicate LC-MS runs from ruptured E. Coli cells and
a set of 14 LC-MS runs of human serum samples.
Jeffries provides a data set consisting of raw replicates
of SELDI data [26] at http://data.ninds.nih.gov/Jeffries/
alignment/index.html.
The SuperHirn data set [27] can be found at http://
proteomics.ethz.ch/muellelu/web/Latin_Square_Data.
php. It consists of 18 LC-MS runs from tryptic digests
of 6 nonhuman proteins spiked with different concen-
trations into a complex human peptide sample and
includes the raw as well as processed data. The data was
obtained on an FT-LTQ.
Problems of interest
Among the data processing portion of the MS-omics
pipeline, some problems are widely studied, and some
are emerging. All provide future research potential.
In silico simulation
The lack of ground truth data for evaluation of data
processing algorithms precludes effective validation and
comparison. In silico data simulation is a relatively new
approach to providing on demand ground truth simu-
lated data. By modeling a list of analytes and a descrip-
tion of experimental conditions, simulators can provide
estimates of mass spectrometer output combined with
labels of the analytes and quantities used in silico to
generate the data (see [28-31]).
Correcting mass shift
Analyte detection on the m/z axis in mass spectrometers
is subject to two types of error: systematic mass error–a
functional deviation from true mass–and random mass
error [32]. Typically, systematic mass error is mitigated
by routine machine recalibration–a process wherein
analytes of known mass are processed in the mass spec-
trometer to create a model that is used to interpolate
m/z shift for any given m/z value. However, the efficacy
of this calibration reduces over time as the mass con-
stantly continues to shift. Additionally, some machines
benefit from an injection of spiked standards during a
normal experiment for internal calibration, which helps
overcome the temporal effects of space charge effects,
electric fields, peak intensity, and temperature [32].
Internal standards are undesirable due to the additional
cost of standards and the suppression implications of
spiked standards. Computational mass calibration tech-
niques have been proposed in order to provide the mass
accuracy of internal calibration but with better consis-
tency and lower cost [32]. This is an active but not
crowded area of research with practical implications.
Correspondence
Correspondence, the registration of recurring signals
from the same analyte over replicate samples, is a crucial
problem in any of the many MS experiments where mul-
tiple runs of similar samples are compared to each other
(see Figure 5). For a comprehensive review of current
algorithms, see [33]. Persisting problems are an abun-
dance of user parameters, models that do not include
known behavior, prohibitively long runtimes, and a lack
of performance comparison between methods [34].
Denoising
MS-omics produces inherently noisy data. Noise can
consist of spurious data points or distortion of a data
point’s true value in retention time, m/z, or intensity.
Denoising as used in MS-omics refers to the removal of
spurious data points. Baseline subtraction is a common
method in which signals with intensity lower than an
adaptive threshold are considered to be noise and
removed (see Figure 6). This is an active area of research,
though most experiments in the literature have not made
an explicit and dedicated study of different techniques,
instead describing the denoising method applied as a
data processing step in a larger experiment.
Feature detection
The most important step of an MS-omics workflow is
undoubtedly feature detection [1], a general term that
can apply to the extraction of various signal elements
from MS data. In chromatographic data, feature detec-
tion can refer to either extracting isotopic envelopes or
isotopic traces from an MS sample output (see Figure 7).
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Many methods exist for isotope trace extraction, among
them a promising new algorithm that performs well on
existing evaluations [35]. Sometimes this process is called
peak picking or peak detection, but those terms should be
avoided since they are also used to refer to the conversion
from profile data to centroid data. In direct injection data,
feature detection is sometimes referred to as peak sum-
marization, since each spectra (being an approximation of
Figure 5 MS correspondence. Correspondence is the problem of registering features across multiple samples (matches across the samples are
depicted in the same color). Most times this process is facilitated by aligning the retention time (RT) of features across multiple samples (top to bottom
row). Note that features are almost never present across all samples and can display significant RT variability and (to a lesser degree) m/z variability.
Figure 6 Baseline subtraction. Baseline subtraction is the functional estimation and removal of background noise.
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the latent content of the non-chromatographically sepa-
rated sample) must be combined into a TIS through
mitigating the variance inherent in m/z across spectra
(see [36]).
Data structures
As described earlier, many data types exist for MS-
omics data. New data formats continue to be proposed
to meet unforeseen needs.
A recent prevailing expansion point has been the need
to store the results of data processing tools in addition
to the original data. Truly modular pipelines require
data structures that contain all necessary data to be
used by any tool in the pipeline, meaning previous mod-
ifications are annotated in addition to retention of the
original data. APML is one attempted solution to this
problem, but, so far, the community has not embraced
it, as it appears that there are only two extant algo-
rithms which use it [22].
There is still a need for compact, random access, and
information rich data structures and access for MS data
[37]. What’s more, some proprietary formats can still only
be converted to open formats on Windows platforms.
Identification
As discussed earlier, mass spectral identifications may be
based on several factors, but two inputs, the precursor
mass (the mass of the molecule) and the fragmentation
pattern (through MS/MS) of the precursor mass, are by
far the most common identifiers. This spectral information
provides a fingerprint unique to most biological molecules;
however, low quality spectra cause false positives and false
negatives. While improving mass spectrometry will cer-
tainly improve spectral quality, improving spectral search
algorithms and employing new identification inputs will
allow for more confident identifications. This is particu-
larly true for the relatively new fields of metabolomics and
lipidomics.
Predicting RT
Retention time refers to the amount of time an analyte is
delayed by chromatography before exiting and being
detected by the mass spectrometer. Retention time is cor-
related with physical and chemical analyte characteristics;
therefore, predicting analyte retention time provides
another factor for positive identification. Many peptide
retention time prediction strategies exist [38]. However,
cross instrument retention times vary greatly due to
changes in experimental parameters, creating a real need
for retention time normalization as well as retention time
prediction.
Mass variance correction
Mass variance, the difference between the theoretical and
experimental (observed) mass of analytes is an open pro-
blem. One way of correcting mass variance is by using
the weights of the elements of each analyte to predict
m/z locations where a lack of signal is impossible, allow-
ing for the identification of systematic deviation from
theoretical masses in a sample [39]. A similar approach is
Figure 7 Feature detection. Feature detection consists of labeling data points which pertain to individual features (indicated by color here)
while excluding noise points (in black).
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to model such theoretical gaps via a sine curve fitted via a
fast Fourier transform [32]. Accurate m/z values are
essential to analyte identification.
Ontology
According to a recent survey of the field, the biggest
problem in lipidomics is the need for a standardization
of data acquisition and data processing, due to the huge
variability in instruments, protocol and data processing
for lipidomics[40]. The many options and permutations
in the MS pipeline would make for a very long methods
section if explicitly described in a paper–much too long
for any journal’s page limits. Although several partial
ontologies exist (see [41,42]), there is no concise way to
uniquely identify an experiment from start to finish,
including sample preparation, mass spectrometry proto-
col, and post-processing. Existing ontologies are particu-
larly lacking in terms of data processing terms. TODO
cite clarity in concepts
Absolute quantitation
MS signal intensity is related to but not equivalent to
analyte quantity [43,44]. Factors that influence this dis-
crepancy include [45]:
• Ionization efficiency. Not all analytes in a sample
are ionized.
• Enzyme digestion rate. When an enzyme–such as
trypsin–is used to digest proteins into peptides, not
all proteins are completely cleaved. This leads to
less-than-expected signal abundance, as the true
abundance will be diminished by whole proteins
(which are not ionized and therefore not detected),
and incompletely digested proteins (which will be
detected at different m/z than the expected peptide
components).
• Ion suppression. When the quantity of analyte enter-
ing the ionization mechanism at a given time exceeds
the ionization capacity of the ionization mechanism,
only a portion of the analyte is charged [46].
Accurate models of these effects would improve esti-
mates of analyte population in samples, as well as
further advance in silico simulation.
Currently, quantification methods generally fall into one
of three approaches: label free spectral counting, quantifi-
cation via differential stable isotopes, and label free quanti-
fication based on the precursor ion signal intensities [47].
Spectral counting is a method in which peptide signals are
used to create a protein tally–the count of every protein
containing a certain peptide is incremented each time one
of its peptides is identified via MS/MS. Despite its preva-
lence, the accuracy of spectral counting is limited by its
dependence on MS/MS acquisition rates, which, as men-
tioned above, are very low, and its propensity for false
positives, since all proteins containing each detected
peptide are considered as present when in reality only one
need be. Stable isotope labeling methods (SILAC, ICAT,
iTRAQ, and TMT) also have significant limitations (see
[48]). Besides cost and sample prep complications, nearly
all methods increase the number of co-eluting analytes,
creating a bottleneck for the complexity of samples
handled. What’s more, because stable isotope methods tar-
get a small specific list of analytes a priori, they are not
practical in terms of time and money for data-driven dis-
covery, where sample composition is unknown [49].
Modeling dynamic range suppression effect
Dynamic range is a term that describes the minimum
intensity of a detectable signal given a co-eluting analyte
of a higher intensity (see Figure 8). All mass spectro-
meters have a dynamic range limitation. The current
state of the art is 103 - 104, meaning that at a given RT if
one analyte has an intensity of 1.3 × 105, any analyte with
an intensity less than 1.3 × 102 would not be detected.
Fragment ion intensities
Because MS/MS acquisition captures not just the ana-
lyte of interest but also any surrounding precursor ions,
and because fragmentation isn’t a perfect process, frag-
ment ion intensities are not as accurate as desired
[50,4]. Several machine learning approaches have been
proposed for making more accurate fragment identifica-
tions [51,52]. However, this is still an open problem.
De novo peptide sequencing
De novo sequencing is an alternative method to database
matching that accommodates peptides that don’t match
up with the database (caused by mutations, polymorph-
isms, modified amino acids or simply a missing database
entry) [53]. Here, the original peptide sequence–defined
by a series of letters, each representing an amino acid–is
reconstructed based on the MS/MS fingerprint and the
chemical properties of the analytes. A recent tutorial
provides more detail and resources [54].
Fragmentation patterns for lipids
Proteins have a known cleavage pattern, meaning that
when peptides are fragmented by MS/MS, association to a
peptide is straightforward. Lipids, on the other hand, have
a much more complex form due to a wider vocabulary of
building blocks and a more complicated fragmentation
pattern. To date, no fragmentation rules have been pub-
lished, making MS/MS much less helpful in lipidomics
than proteomics. Because of the complexity of lipids, a
machine learning approach could be appropriate in finding
a solution to this problem.
Biomarker detection
Biomarker discovery is the use of comparative analysis (see
Figure 9) in order to identify analytes that correlate with
certain diseases or other conditions for diagnostics or drug
development. It is an active area of research with a lot of
published work; however the problem is still wide open
due to limitations in mass spectrometry, preprocessing,
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and identification. Current methods struggle to highlight
case/control differences in complex samples, requiring
painstaking, time consuming, and error-prone manual
detection.
Deisotoping
Deisotoping is the process of reducing several instances
of the same analyte at different charge states into a sin-
gle feature–usually a monoisotopic peak (see Figure 3).
This is necessary because the query to a data base
search consists of only the single-charged feature m/z
and (optionally) RT. Adding to the complexity of regis-
tering differently charged versions of the same analyte is
the fact that, in complex samples, the isotopic envelopes
of different analytes can and do overlap, requiring
deconvolution (see below).
Deconvolution
Overlapping signals must be resolved prior to quantifica-
tion (see Figure 10). RT overlaps occur when two isobaric
analyte elute without a gap between them, and are more
common in complex samples. Isotopic envelope overlaps
occur in m/z where two analyte are not sufficiently sepa-
rate in m/z at their current charge state. Ion overlaps
occur when particular ions of two given analyte are too
similar to be resolved in m/z. All m/z overlaps are less
likely in high resolution machines, which by definition are
capable of better resolving power evinced by more narrow
Figure 8 Dynamic range. Dynamic range is the window of intensities visible to the sensor at any given RT. The main chromatogram shows the
signal of maximum intensity for each RT. The gray box indicates the dynamic range at that RT. The red peak is shown with the other signals at
that RT. Note the green peaks will not be detected by the mass spectrometer because they lie outside the dynamic range.
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signals in m/z. RT overlaps can be minimized to some
extent by sample preparation and protocol designed to
separate similar molecules into different RT areas.
Parameter reduction
In general, most algorithms require the user to opti-
mize a host of parameters through manual tuning,
which is time intensive. New algorithms should avoid
free parameters. If included, they should also provide
guidance or an automated method to fix them.
Research opportunities include developing methods for
automatically optimizing parameters on existing and
popular methods.
Conclusions
MS-omics is an exciting, developing field with many
research opportunities for mathematicians, computer
scientists, and statitisticians. Although contribution to
the field requires a functional understanding of many
domain-specific concepts and terms, the open nature of
most of the existing problems provides many opportu-
nities for impact.
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